Insider Transactions in Q2 2024 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
SELL
Open market or private sale
|
Direct |
20,651
-15.41%
|
$867,342
$42.63 P/Share
|
|
May 16
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Exercise of conversion of derivative security
|
Direct |
20,651
+12.6%
|
$144,557
$7.87 P/Share
|
|
May 15
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
SELL
Open market or private sale
|
Direct |
10,186
-8.54%
|
$427,812
$42.42 P/Share
|
|
May 15
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Exercise of conversion of derivative security
|
Direct |
8,221
+11.81%
|
$24,663
$3.94 P/Share
|
|
Apr 10
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
SELL
Open market or private sale
|
Direct |
5,714
-9.7%
|
$228,560
$40.0 P/Share
|
|
Apr 03
2024
|
Sean Grant CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Indirect |
18,649
-47.42%
|
$727,311
$39.16 P/Share
|
|
Apr 03
2024
|
Sean Grant CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
99,828
-19.27%
|
$3,893,292
$39.02 P/Share
|
|
Apr 03
2024
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
99,828
+37.53%
|
$1,397,592
$14.87 P/Share
|